KMT2C and thyroid gland papillary carcinoma: Recently, Wang et al. reported that miR-181a inhibited DACT2 by downregulating mixed-lineage leukemia 3(MLL3) expression in human umbilical vein endothelial cells, resulting in papillary thyroid cancer progression 70.